SMI
12 652,54
|
122,96
|
0,98 %
|
Analysen zu SMI-Werten
13:05 | Nestlé Market-Perform | Bernstein Research | |
13:05 | ABB Underperform | Bernstein Research | |
12:40 | Roche Kaufen | DZ BANK | |
12:27 | Nestlé Neutral | JP Morgan Chase & Co. | |
12:10 | ABB Sector Perform | RBC Capital Markets | |
12:04 | Nestlé Neutral | UBS AG | |
11:50 | Nestlé Sector Perform | RBC Capital Markets | |
11:43 | Nestlé Hold | Jefferies & Company Inc. | |
09:23 | ABB Neutral | JP Morgan Chase & Co. | |
08:43 | Richemont Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
15.10.25 | Nestlé Hold | Deutsche Bank AG | |
15.10.25 | Givaudan Hold | Deutsche Bank AG | |
15.10.25 | Givaudan Buy | Goldman Sachs Group Inc. | |
15.10.25 | Givaudan Neutral | UBS AG | |
15.10.25 | Givaudan Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
14.10.25 | ABB Sector Perform | RBC Capital Markets | |
14.10.25 | Givaudan Neutral | UBS AG | |
14.10.25 | Givaudan Hold | Jefferies & Company Inc. | |
14.10.25 | Givaudan Neutral | JP Morgan Chase & Co. | |
13.10.25 | Swiss Re Underperform | RBC Capital Markets | |
13.10.25 | Roche Buy | UBS AG | |
13.10.25 | Novartis Neutral | UBS AG | |
13.10.25 | Roche Underweight | JP Morgan Chase & Co. | |
10.10.25 | Novartis Neutral | UBS AG | |
10.10.25 | ABB Sell | Deutsche Bank AG | |
10.10.25 | Richemont Overweight | JP Morgan Chase & Co. | |
10.10.25 | Nestlé Neutral | JP Morgan Chase & Co. | |
09.10.25 | ABB Neutral | Goldman Sachs Group Inc. | |
09.10.25 | ABB Sell | Deutsche Bank AG | |
09.10.25 | Richemont Hold | Deutsche Bank AG | |
09.10.25 | Givaudan Neutral | JP Morgan Chase & Co. | |
08.10.25 | Swiss Re Hold | Jefferies & Company Inc. | |
08.10.25 | Zurich Insurance Hold | Jefferies & Company Inc. | |
08.10.25 | Givaudan Hold | Jefferies & Company Inc. | |
08.10.25 | ABB Sector Perform | RBC Capital Markets | |
08.10.25 | UBS Buy | Deutsche Bank AG | |
08.10.25 | ABB Neutral | JP Morgan Chase & Co. | |
08.10.25 | Givaudan Overweight | JP Morgan Chase & Co. | |
08.10.25 | Givaudan Neutral | UBS AG | |
08.10.25 | Roche Underweight | JP Morgan Chase & Co. |